OpenClinica unveils Participate™ to capture research data directly from patients
Participate sets a new standard for usability, integration, and cost effectiveness for electronic patient reported outcomes (ePRO).
BOSTON, June 9, 2015 /PRNewswire/ -- OpenClinica announced today the availability of Participate, a mobile, device independent solution for engaging participants in clinical research. Participate broadens possibilities for clinical research, by making it easier to meaningfully engage patients and collect high quality, timely data from patients in a way that is convenient for them.
Photo - http://photos.prnewswire.com/prnh/20150608/221555
OpenClinica will be hosting two webinars to demonstrate Participate:
Register: Introducing OpenClinica Participate
To date, OpenClinica has been known for its clinical trial electronic data capture software, widely used by biopharma, medical device, CRO, and academic researchers. The addition of Participate adds a friendly and effective way to engage patients directly in those same OpenClinica-powered clinical studies.
"Collecting accurate, timely, useful data directly from patients has been a longstanding challenge for clinical research," said OpenClinica's Alicia Goodwin, who helped design Participate. "Researchers have either relied on antiquated paper diaries or the provisioning of additional devices to patients, both of which are expensive, logistically complex, and unreliable. Participate makes it easy to create and send forms directly to study participants in a simple and secure interface on their own smartphone, tablet, or PC. With the state of technology today, we believe there is no longer a need to use paper PROs alongside EDC, or engage multiple specialized vendors resulting in siloed data sets and integration complexity."
Using Participate with OpenClinica EDC allows researchers to design participant-facing events, reminders, and assessments alongside clinical visits and CRFs, using OpenClinica's existing, user-friendly study build tools. All the clinical and patient reported outcomes data are seamlessly captured in a single place. As data are submitted by study participants, their activities become part of the same regulatory compliant audit trail that tracks all clinical user activity. The data participants submit, are immediately available for review and analysis alongside CRF data from other sources.
"The difficulty of engaging with study volunteers in a meaningful and timely way is as an obstacle to successful research. We live in a world where 90% of adults have smartphones, 81% text, and 63% use their phone to go online. We need to reach patients on their terms, whether email, SMS, web, or a mobile device," said Cal Collins, OpenClinica's CEO. "Treating research volunteers as participants, as opposed to subjects, can lead to concrete benefits, such as improved compliance more effective recruiting, and more complete, timely data. It can even help enable new protocol designs that better target populations and/or more closely align with real-world use. But most of all, it just seems like the right thing to do."
OpenClinica Participate will be showcased at the upcoming OpenClinica Global Conference, May 31-June 1 in Amsterdam and DIA 2015 (Booth 635) in Washington DC, June 14-18.
About OpenClinica, LLC
OpenClinica, LLC provides the most widely-adopted open source software for electronically capturing clinical research data. With thousands of implementations at biopharmaceutical companies, contract research organizations, academic, and government organizations worldwide, the OpenClinica software facilitates electronic data capture (EDC), clinical data management, and electronic patient reported outcomes (ePRO), increasing the speed of collection and quality of data in clinical trials. OpenClinica supports HIPAA, 21 CFR Part 11, and other regulatory guidelines and is designed as a standards-based, extensible, and modular platform. For more information, visit http://www.openclinica.com and https://participate.openclinica.com.
Media Contact: Robert Rittberg, 1-781-547-8416, [email protected]
SOURCE OpenClinica
Share this article